BioCardia, Inc. (BCDA) CEO Peter Altman on Q2 2022 Results - Earnings Call Transcript

BioCardia, Inc. (NASDAQ:BCDA) Q2 2022 Earnings Conference Call August 10, 2022 4:30 PM ET

Company Participants

Jules Abraham - IR, CORE IR
Peter Altman - President and CEO
David McClung - CFO

Conference Call Participants

Kumaraguru Raja - Brookline Capital Markets
Michael Okunewitch - Maxim Group
James Molloy - Alliance Global Partners

Operator

Ladies and gentlemen, thank you for standing by. Good day and welcome to the BioCardia 2022 Second Quarter Conference Call. [Operator Instructions] Participants of this call are advised that the audio of this conference call is being broadcast live over the Internet and is also being recorded for playback purposes. A webcast replay of the call will be available approximately one hour after the end of the call through August 24, 2022.

I would now like to turn the conference over to Jules Abraham of CORE IR, the company's Investor Relations firm. Please go ahead sir.

Jules Abraham

Thank you, [Teka]. Good afternoon, everyone, and thank you for participating in today's conference call. Joining me from BioCardia leadership team today are Peter Altman Ph.D, President and Chief Executive Officer; and David McClung, the Company's Chief Financial Officer.

During this call, management will be making forward-looking statements, including statements that address BioCardia's expectations for future performance or operational results, references to management's intentions, beliefs, projections, outlook, analysis or current expectations. Such factors include among others, the inherent uncertainties associated with developing new products or technologies and obtaining regulatory approvals.

Forward-looking statements involve risks and other factors that may cause actual results to differ materially from those statements. For more information about these risks, please refer to the risk factors described in BioCardia's most recently filed periodic reports on Form 10-K, Form 10-Q and Form 8-K filed with the SEC, particularly the cautionary statements in them. The content of this call contains time sensitive